Risk Assessment & Prognosis

Malignin antibody as early warning

E Bogoch, MD, S Bogoch, MD, PhD

Evaluation of antibodies to the epstein-barr virus transactivator, zebra, for early diagnosis and post-therapeutic surveillance of nasopharygeal carcinoma

1. J0AB, JC NICOLAS, C COCHET, G SCHWAAB, B CLAUSSE, Y ZENG

Usefulness of tumor markers both in the diagnosis of primary colorectal cancer and at relapse

A Nicolini, C Colombini, M Caciagli, G Giuliani, G Ciampalini, F Zarnpieri, M Da Prato, L Giuliani

Carcinogen metabolism and DNA adducts in patients at high risk for intestinal cancer and in controls

AD SPIGELMAN, S VENITT, DK SCATES KP NUGENT, C PENNA, S FOULDS, PN BENNETT, RKS PHILLIPS

Preliminary study on the diagnostic value of serum alcohol dehydrgenase in primary hepatoma

IO Ogunleye, PhD; SO Olusi, PhD

Variation in body fat distribution and cancer risk within families

DV Schapira, N Kumar, G Lyman

Body iron stores and the risk of colorectal cancer

P Knekt PHD, A Reunanen MD, H Takkunen MD, A Aromaa MD, M Heliovaara MD, T Hakulinen ScD

Regulation of T cell responses by interleukin-2 and its receptor in patients with hodgkin's disease

N Rajaram, RN Damle, SG Gangal

Evaluation of new tumor marker CYFRA 21-1 as predictor for early recurrence in non-small cell lung cancer

J Niklinski, M Furman, J Moniuszko-Jakoniuk, J Laudaniski, W Kedzierska

A clinicopathological analysis of early gastric cancer; retrospective study for the prediction of lymph node metastasis

A Torii MD, S Ueda MD, M Okuma MD, M Sakai MD, K Inoue MO, H Yamabe MD

Gallbladder mucosal changes in patients with anomalous arrangement of the pancreaticobiliary duct

K Tokiwa MD, K Nakamura MD, N Iwai MD, T Yamane MD , K Oya MD, M Inagake MD

Distribution and activity of ornithine decarboxylase in colorectal cancer using anti human ODC monoclonal antibody

K Oya, T Yamane, M Inagake, Y Kitao, A Okuyama, T Takahashi, K Nakamura, K Tokiwa, S Irie, K Nakayama, K Wadama

Immunohistochemical examination in the gallbladder mucosa in children with anomalous arrangement of the pancreaticobiliary duct

K Nakamura, K Tokiwa, N Iwai, K Oya, M Inagake, T Yamane, S Irie

Expression of non-polymorphic HLA class II (DR) antigens as a predictive factor of complete remission duration in children acute lymphoblastic leukemia

N Tupitsyn MD, S Mayakova, LA Makhonova MD, ZG Kadagidze MD, BV Kurdjukov